The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.
Abstract
PURPOSE: This is the first published report on the validation of the Functional Assessment of Cancer Therapy-Breast (FACT-B), a 44-item self-report instrument designed to measure multidimensional quality of life (QL) in patients with breast cancer. The FACT-B consists of the FACT-General (FACT-G) plus the Breast Cancer Subscale (BCS), which complements the general scale with items specific to QL in breast cancer. The FACT-B was developed with an emphasis on patients' values and brevity and is available in nine languages. METHODS AND RESULTS: Two validation samples were used for this report. The first (n = 47) was tested twice over a 2-month period to assess sensitivity to change. Significant sensitivity to change in performance status rating (PSR) was demonstrated for the FACT-B total score, the Physical Well-Being (PWB) subscale, the Functional Well-Being (FWB) subscale, and the BCS. Sensitivity to change in QL as measured by the Functional Living Index-Cancer (FLIC) was documented in the FACT-B total score, PWB, FWB, and Emotional Well-Being (EWB). Additional validity and reliability data were obtained from a larger sample (n = 295). The alpha coefficient (internal consistency) for the FACT-B total score was high (alpha = .90), with subscale alpha coefficients ranging from .63 to .86. Evidence supported test-retest reliability, as well as convergent, divergent, and known groups validity. CONCLUSION: The FACT-B is appropriate for use in oncology clinical trials, as well as in clinical practice. It demonstrates ease of administration, brevity, reliability, validity, and sensitivity to change.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The observed mean improvements presented within this evaluation exceeded this for both groups.”
In the citing paper
“All measures were validated, brief, and non-redundant, supporting parsimony while enabling comprehensive evaluation of intervention impact.”
Citations
Cites
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Impact of Event Scale: A Measure of Subjective Stress
Horowitz, M., Wilner, N., & Alvarez, W. (1979) · Psychosomatic Medicine · doi:10.1097/00006842-197905000-00004 · Cited by 7,813
MCHORNEY, C. A., JOHNE, W., & ANASTASIAE, R. (1993) · Medical Care · doi:10.1097/00005650-199303000-00006 · Cited by 6,681
The functional assessment of cancer therapy scale: development and validation of the general measure
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S. B., Winicour, P., & Brannon, J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.570 · Cited by 6,020
Self-citationShort, homogeneous versions of the Marlow-Crowne Social Desirability Scale
Strahan, R. F., & Gerbasi, K. C. (1972) · Journal of Clinical Psychology · doi:10.1002/1097-4679(197204)28:2 · Cited by 1,657
Sprangers, M. A., Groenvold, M., Arraras, J. I., Franklin, J., te Velde, A., Muller, M., Franzini, L., Williams, A., de Haes, H. C., Hopwood, P., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2756 · Cited by 1,220
Estimates of the worldwide frequency of sixteen major cancers in 1980
Parkin, D. M., Läärä, E., & Muir, C. S. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910410205 · Cited by 1,057
Schipper, H., Clinch, J., McMurray, A., & Levitt, M. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.5.472 · Cited by 1,052
Zubrod, C. G., Schneiderman, M. A., Frei, E., Brindley, C. O., Gold, G. L., Shnider, B. I., Oviedo, R., Gorman, J. G., Jones, R., Jonsson, U., et al. (1960) · Journal of Chronic Diseases · doi:10.1016/0021-9681(60)90137-5 · Cited by 1,034
Who should measure quality of life, the doctor or the patient?
Slevin, M., Plant, H., Lynch, D., Drinkwater, J., & Gregory, W. M. (1988) · British Journal of Cancer · doi:10.1038/bjc.1988.20 · Cited by 903
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 1,004
Disability and Health-Related Quality of Life after Breast Cancer Surgery: Relation to Impairments
Kaya, T., Karatepe, A. G., Günaydın, R., Yetiş, H., & Uslu, A. (2010) · Southern Medical Journal · doi:10.1097/smj.0b013e3181c38c41 · Cited by 86
“The former subscale includes questions about faith to cope with disease, nervousness, and fear of death, while the latter deals with questions related to the problems of appearance and course of the disease which are, to a great extent, specific to the patient’s surgical intervention.(15) Actually, pain after breast c…”
BackgroundMethodInfluentialJeffery, D. D., Tzeng, J., Keefe, F. J., Porter, L. S., Hahn, E. A., Flynn, K. E., Reeve, B. B., & Weinfurt, K. P. (2009) · Cancer · doi:10.1002/cncr.24134 · Cited by 87
Shaw, B. R., Han, J. Y., Kim, E., Gustafson, D. H., Hawkins, R. P., Cleary, J. F., Mctavish, F. M., Pingree, S., Eliason, P., & Lumpkins, C. Y. (2006) · Psycho-Oncology · doi:10.1002/pon.1129 · Cited by 86
Prevalence and Prognostic Significance of Secondary Lymphedema Following Breast Cancer
Hayes, S. C., DiSipio, T., Rye, S., López, J. A., Saunders, C. M., Pyke, C., Bashford, J., Battistutta, D., & Newman, B. M. (2011) · Lymphatic Research and Biology · doi:10.1089/lrb.2011.0007 · Cited by 86
Differences in What Quality-of-Life Instruments Measure
Ferrans, C. E. (2007) · JNCI Monographs · doi:10.1093/jncimonographs/lgm008 · Cited by 86
Leading the Way in Exercise and Diet (Project LEAD):
Demark‐Wahnefried, W., Morey, M. C., Clipp, E. C., Pieper, C. F., Snyder, D. C., Sloane, R. J., & Cohen, H. J. (2003) · Controlled Clinical Trials · doi:10.1016/s0197-2456(02)00266-0 · Cited by 86
Oberguggenberger, A., Michael, H., Sztankay, M. J., Meraner, V., Beer, B., Oberacher, H., Giesinger, J. M., Kemmler, G., Egle, D., Gamper, E., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1378-5 · Cited by 84
An, K., Morielli, A. R., Kang, D., Friedenreich, C. M., McKenzie, D. C., Gelmon, K. A., Mackey, J. R., Reid, R. D., & Courneya, K. S. (2019) · International Journal of Cancer · doi:10.1002/ijc.32493 · Cited by 85
“COMB 136 (185) 232 (18) 265 (21) 253 (22) Resistance exercise (days/week)(1)”
Hormonal therapies for early breast cancer: systematic review and economic evaluation
Hind, D., Ward, S. E., Nigris, E. D., Simpson, E. L., Carroll, C., & Wyld, L. (2007) · Health Technology Assessment · doi:10.3310/hta11260 · Cited by 85
Comparing Three Life-Limiting Diseases: Does Diagnosis Matter or Is Sick, Sick?
Steinhauser, K. E., Arnold, R. M., Olsen, M. K., Lindquist, J. H., Hays, J. C., Wood, L. L., Burton-Chase, A. M., & Tulsky, J. A. (2011) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2010.11.006 · Cited by 84
Kassianos, A. P., Ioannou, M., Koutsantoni, M., & Charalambous, H. (2017) · Supportive Care in Cancer · doi:10.1007/s00520-017-3895-1 · Cited by 93
Baseline cognitive functions among elderly patients with localised breast cancer
Lange, M., Giffard, B., Noal, S., Rigal, O., Kurtz, J., Heutte, N., Lévy, C., Allouache, D., Rieux, C., Fel, J. L., et al. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.05.026 · Cited by 83
“State-Trait Anxiety Inventory – STAI [17]), fatigue (Functional Assessment of Chronic Illness TherapyFatigue – FACIT-Fatigue, version 4 [18]) and quality of life (FACT-Breast – FACT-B, version 4 [19] incorporates FACT-General – FACT-G, version 4 [20]).”
Li, L., Zhu, X., Yang, Y., He, J., Yi, J., Wang, Y., & Zhang, J. (2015) · Health and Quality of Life Outcomes · doi:10.1186/s12955-015-0242-4 · Cited by 84
Lahart, I. M., Metsios, G. S., Nevill, A. M., Kitas, G. D., & Carmichael, A. R. (2016) · BMC Cancer · doi:10.1186/s12885-016-2258-5 · Cited by 82
The psychosocial determinants of quality of life in breast cancer survivors: a scoping review
Culbertson, M. G., Bennett, K., Kelly, C. M., Sharp, L., & Cahir, C. (2020) · BMC Cancer · doi:10.1186/s12885-020-07389-w · Cited by 98
Kim, S. C., Shah, D. V., Namkoong, K., Mctavish, F. M., & Gustafson, D. H. (2013) · Journal of Computer-Mediated Communication · doi:10.1111/jcc4.12002 · Cited by 92
A Randomized Trial of Weekly Symptom Telemonitoring in Advanced Lung Cancer
Yount, S., Rothrock, N. E., Bass, M., Beaumont, J. L., Pach, D., Lad, T. E., Patel, J. D., Corona, M., Weiland, R., Ciello, K. D., et al. (2013) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2013.07.013 · Cited by 83
Self-citationKirsh, K. L., Passik, S. D., Holtsclaw, E., Donaghy, K. B., & Theobald, D. (2001) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(01)00350-5 · Cited by 83
Temple, C. L. F., Ross, D. C., Kim, S. H., Tse, R. W., Bettger‐Hahn, M., Gan, B. S., & MacDermid, J. C. (2009) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e3181b98963 · Cited by 81
Validity and reliability of EQ-5D-3L for breast cancer patients in Korea
Kim, S., Jo, M., Lee, J.-W., Lee, H., & Kim, J. K. (2015) · Health and Quality of Life Outcomes · doi:10.1186/s12955-015-0399-x · Cited by 81
“FACT-G scores were calculated as the sum of the PWB, FWB, EWB, and SWB scores and FACT-B Trial Outcome Index (TOI) was calculated as the addition of the PWB, FWB and BCS scores [15, 16].”
MethodAn online stress management workbook for breast cancer
Carpenter, K. M., Stoner, S. A., Schmitz, K., McGregor, B. A., & Doorenbos, A. Z. (2014) · Journal of Behavioral Medicine · doi:10.1007/s10865-012-9481-6 · Cited by 80
“Social and functional well-being were assessed with the Functional Assessment of Cancer Therapy-Breast (Brady et al., 1997), which consists of thirty-seven items rated on a 5-point Likert scale with response options ranging from 0, not at all, to 4, very much.”
MethodSurgical Outcomes after Breast Cancer Surgery: Measuring Acute Lymphedema
Kosir, M. A., Rymal, C., Koppolu, P., Hryniuk, L. E., Darga, L. L., Du, W., Rice, V. H., Mood, D., Shakoor, S., Wang, W., et al. (2001) · Journal of Surgical Research · doi:10.1006/jsre.2000.6021 · Cited by 80
“Quality of life (QOL) was measured perioperatively using he Functional Assessment of Cancer Treatment–Breast (FACT-B), hich is a multidimensional QOL tool used frequently in breast ancer studies [12, 13].”
MethodBan, Y., Li, M., Yu, M., & Wu, H. L. (2021) · Health and Quality of Life Outcomes · doi:10.1186/s12955-021-01816-7 · Cited by 85
Quality of Life Differences between Younger and Older Breast Cancer Patients
Park, B., Lee, S., Lee, A. R., Lee, K.-H., & Hwang, S. Y. (2011) · Journal of Breast Cancer · doi:10.4048/jbc.2011.14.2.112 · Cited by 80
Short-term effects of telephone therapy for breast cancer patients.
Sandgren, A. K., & McCaul, K. D. (2003) · Health Psychology · doi:10.1037/0278-6133.22.3.310 · Cited by 80
Nápoles, A. M., Ortíz, C., Santoyo-Olsson, J., Stewart, A. L., Gregorich, S., Lee, H. E., Durón, Y., McGuire, P., & Luce, J. (2015) · American Journal of Public Health · doi:10.2105/ajph.2015.302598 · Cited by 77
Peddle‐McIntyre, C. J., Bell, G. J., Fenton, D. W., McCargar, L., & Courneya, K. S. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.05.026 · Cited by 78
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer
Sonke, G. S., van Ommen‐Nijhof, A., Wortelboer, N., van der Noort, V., Swinkels, A. C. P., Blommestein, H. M., Páez, C. G., Mol, L., Beeker, A., Beelen, K. J., et al. (2024) · Nature · doi:10.1038/s41586-024-08035-2 · Cited by 89
Hegel, M. T., Lyons, K. D., Hull, J. G., Kaufman, P. A., Urquhart, L., Li, Z., & Ahles, T. A. (2010) · Psycho-Oncology · doi:10.1002/pon.1830 · Cited by 80
Stein, R. C., Dunn, J., Bartlett, J. M. S., Campbell, A. F., Marshall, A., Hall, P. S., Rooshenas, L., Morgan, A. A., Poole, C. J., Pinder, S. E., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20100 · Cited by 82
Soriano‐Maldonado, A., Carrera-Ruiz, Á., Díez‐Fernández, D. M., Esteban‐Simón, A., Maldonado-Quesada, M., Moreno-Poza, N., García-Martínez, M. D. M., Alcaraz‐García, C., Vázquez-Sousa, R., Moreno-Martos, H., et al. (2019) · Medicine · doi:10.1097/md.0000000000017625 · Cited by 82
“Cancer specific quality of life will also be assessed with the Spanish version([67]) of the Functional Assessment of Cancer Therapy-Breast (FACT-B)([68]).”
MethodJuraskova, I., Jarvis, S. K., Mok, K., Peate, M., Meiser, B., Cheah, B. C., Mireskandari, S., & Friedlander, M. L. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12156 · Cited by 80
Namkoong, K., Shah, D. V., Han, J. Y., Kim, S. C., Yoo, W., Fan, D. P., Mctavish, F. M., & Gustafson, D. H. (2010) · Patient Education and Counseling · doi:10.1016/j.pec.2010.09.009 · Cited by 78
Tercyak, K. P., Peshkin, B. N., Brogan, B. M., DeMarco, T. A., Pennanen, M. F., Willey, S. C., Magnant, C. M., Rogers, S., Isaacs, C. J., & Schwartz, M. D. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.3890 · Cited by 78
Quality of Life after Treatment for Gynecologic Malignancies: A Pilot Study in an Outpatient Clinic
Miller, B. E., Pittman, B., Case, D., & McQuellon, R. P. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2002.6812 · Cited by 78
Taking Stock of Health-Related Quality-of-Life Measurement in Oncology Practice in the United States
Donaldson, M. S. (2004) · JNCI Monographs · doi:10.1093/jncimonographs/lgh017 · Cited by 78
Dolan, L. B., Barry, D., Petrella, T. M., Davey, L., Minnes, A., Yantzi, A., Marzolini, S., & OH, P. I. (2017) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/hcr.0000000000000256 · Cited by 82
Design of FRESH START: A Randomized Trial of Exercise and Diet among Cancer Survivors
Demark‐Wahnefried, W., Clipp, E. C., McBride, C. M., Lobach, D. F., Lipkus, I. M., Peterson, B. L., Snyder, D. C., Sloane, R. J., Arbanas, J. M., & Kraus, W. E. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000053704.28156.0f · Cited by 77
A weight loss intervention for African American breast cancer survivors, 2006.
Stolley, M. R., Sharp, L. K., Oh, A., & Schiffer, L. A. (2009) · PubMed Central · Cited by 77
Shaitelman, S. F., Lei, X. J., Thompson, A. M., Schlembach, P. J., Bloom, E. S., Arzu, I., Buchholz, D. J., Chronowski, G. M., Dvořák, T., Grade, E., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.18.00317 · Cited by 76
“0 toxicities (n = 112) (n = 110) (n = 111) (n = 111) (n = 106) (n = 108) Allocated to HF-WBI Received allocated intervention Did not receive allocated intervention Received CF-WBI per MD recommendation (n = 137) (n = 1) (n = 138) 3-year follow-up Had information on any endpoint Analyzed for BCTOS-cosmesis and treating…”
MethodInfluentialLarson, J. L., Rosen, A. B., & Wilson, F. A. (2019) · Health Informatics Journal · doi:10.1177/1460458219863604 · Cited by 81
Loughney, L. A., West, M. A., Kemp, G. J., Grocott, M. P. W., & Jack, S. (2015) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2015.08.153 · Cited by 76
Hill, A. R., McQuellon, R. P., Russell, G. B., Shen, P., Stewart, J. H., & Levine, E. A. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1793-1 · Cited by 76
Cavalheri, V., JENKINS, S. C., Cecins, N. M., Gain, K. R., Phillips, M. J., Sanders, L. H. A., & Hill, K. (2017) · Brazilian Journal of Physical Therapy · doi:10.1016/j.bjpt.2016.12.005 · Cited by 76
Hypofractionated radiation therapy for early breast cancer
Hickey, B. E., James, M. L., Lehman, M., Hider, P. N., Jeffery, M., Francis, D. P., & See, A. M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003860.pub4 · Cited by 78
Acquati, C., & Kayser, K. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.00404 · Cited by 76
“The quality of life of women diagnosed with breast cancer was measured by the Functional Assessment of Cancer TherapyBreast (FACT-B) Scale (Cella et al., 1993; Brady et al., 1997).”
MethodInfluentialA Diet and Exercise Intervention during Chemotherapy for Breast Cancer
Djurić, Z. (2011) · The Open Obesity Journal · doi:10.2174/1876823701103010087 · Cited by 75
“for women undergoing breast cancer treatment [56].”
Rogers, L. Q., McAuley, E., Anton, P. M., Courneya, K. S., Vicari, S. K., Hopkins-Price, P. L., Verhulst, S. J., Mocharnuk, R. S., & Hoelzer, K. L. (2011) · Contemporary Clinical Trials · doi:10.1016/j.cct.2011.09.004 · Cited by 77
“Using the sum of 5-point Likert scales, the 37-item FACT-B instrument includes the subscales of physical well-being (PWB), social well-being (SWB), emotional well-being (EWB), functional well-being (FWB), and additional concerns (AC) [47].”
BackgroundMethodResultInfluentialMaintenance of Physical Activity in Breast Cancer Survivors after a Randomized Trial
Vallance, J. K., Courneya, K. S., Plotnikoff, R. C., Dinu, I. A., & Mackey, J. R. (2008) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181586b41 · Cited by 75
Does Chemotherapy Really Affect the Quality of Life of Women with Breast Cancer?
Hwang, S. Y., Chang, S. J., & Park, B. (2013) · Journal of Breast Cancer · doi:10.4048/jbc.2013.16.2.229 · Cited by 75
Avis, N. E., Ip, E. H., & Foley, K. L. (2006) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-4-92 · Cited by 81
Carlson, L. E., Tamagawa, R., Stephen, J., Doll, R., Faris, P., Dirkse, D., & Speca, M. (2014) · JNCI Monographs · doi:10.1093/jncimonographs/lgu034 · Cited by 69
Activity Tracker to Prescribe Various Exercise Intensities in Breast Cancer Survivors
McNeil, J., Brenner, D. R., Stone, C. R., O’Reilly, R., Ruan, Y., Vallance, J. K., Courneya, K. S., Thorpe, K. E., Klein, D., & Friedenreich, C. M. (2019) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001890 · Cited by 74
Cervical cancer survivorship in a population based sample
Ashing‐Giwa, K. T., Tejero, J. S., Kim, J., PADILLA, G. V., Kagawa‐Singer, M., Tucker, M. B., & Lim, J. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.11.002 · Cited by 74
Sturgeon, M. M., Wetta‐Hall, R., Hart, T. A., Good, M., & Dakhil, S. R. (2009) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2008.0399 · Cited by 74
“44 The study was approved by the institutional review boards of the Via Christi Regional Medical Center, University of Kansas School of Medicine–Wichita, and Wichita Medical Research and Education Foundation.”
Garland, S. N., Pelletier, G., Lawe, A., Biagioni, B. J., Easaw, J., Eliasziw, M., Cella, D. F., & Bathe, O. F. (2010) · Cancer · doi:10.1002/cncr.25556 · Cited by 74
“This may be the case for the FACT-G, for which previous reports demonstrated higher Cronbach a values.(15,27) A lower Cronbach a value also may occur with scales that contain a question coded in the opposite direction from other questions in the scale (for instance, ‘‘I am satisfied with how I am coping with my illnes…”
ResultSelf-citationYoo, H. J., Ahn, S. H., Eremenco, S. L., Kim, I. H., Kim, W. K., Kim, S. B., & Han, O. S. (2005) · Quality of Life Research · doi:10.1007/s11136-004-7712-1 · Cited by 74
“It consists of 36 items, which are subdivided into four primary Quality of Life (QoL) domains (Physical Well-Being (PWB), Social/Family Well-Being (SFWB), Emotional Well-Being (EWB), and Functional Well-Being (FWB)) and contains additional concerns for breast cancer [1, 2].”
BackgroundMethodResultBernhard, J., Hürny, C., Coates, A. S., Peterson, H. F., Castiglione‐Gertsch, M., Gelber, R. D., Goldhirsch, A., Senn, H. J., & Rudenstam, C.-M. (1997) · Annals of Oncology · doi:10.1023/a:1008269715091 · Cited by 74
Does Rurality Affect Quality of Life Following Treatment for Breast Cancer?
Reid‐Arndt, S. A., & Cox, C. R. (2010) · The Journal of Rural Health · doi:10.1111/j.1748-0361.2010.00295.x · Cited by 73
“Two measures were used to assess QOL: a single-item question (“In general, how satisfied are you with your overall QOL?”) using a 5-point Likert scale, and the Functional Assessment of Cancer Therapy-Breast (FACTB).(19) The FACT-B has 44 items across 6 subscales: Physical Well-Being (PWB), Social/Family Well-Being (SW…”
MethodThrough the lens of culture: quality of life among Latina breast cancer survivors
Graves, K. D., Jensen, R. E., Cañar, J., Perret-Gentil, M., Leventhal, K., González, F., Caicedo, L., Jandorf, L. H., Kelly, S. P., & Mandelblatt, J. S. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2291-2 · Cited by 72
Gellaitry, G., Peters, K., Bloomfield, D. J., & Horne, R. (2009) · Psycho-Oncology · doi:10.1002/pon.1532 · Cited by 73
“Quality of life (QOL) was assessed using the Functional Assessment of Cancer Therapy—Breast [25], a 36-item self-report instrument designed to measure multidimensional QOL in patients with breast cancer.”
MethodHack, T. F., Pickles, T., Bultz, B. D., Ruether, J. D., Weir, L. M., Degner, L. F., & Mackey, J. R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.155 · Cited by 73
Quality of life measurement in oncology—a matter of the assessment instrument?
Holzner, B., Kemmler, G., Sperner‐Unterweger, B., Kopp, M., Dünser, M., Margreiter, R., Marschitz, I., Nachbaur, D., Fleischhacker, W. W., & Greil, R. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00307-0 · Cited by 73
“The two questionnaires are used worldwide and have been shown to have good validity and reliability properties both for the original English instrument and the translations into various languages, including German [12,14–22].”
BackgroundSoriano‐Maldonado, A., Díez‐Fernández, D. M., Esteban‐Simón, A., Rodríguez-Pérez, M. A., Artés-Rodríguez, E., Casimiro-Artés, M. Á., Moreno-Martos, H., Toro-de-Federico, A., Hachem-Salas, N., Bartholdy, C. R., et al. (2022) · Journal of Cancer Survivorship · doi:10.1007/s11764-022-01192-1 · Cited by 85
“Health-related quality of life was assessed with the patient-reported Functional Assessment of Cancer Therapy-Breast (FACT-B) [61].”
MethodSiddiqui, F., Pajak, T. F., Bruner, D. W., Konski, A. A., Coyne, J. C., Gwede, C. K., Garden, A. S., Spencer, S. A., Jones, C. U., & Movsas, B. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.06.024 · Cited by 72
Galantino, M. L., Greene, L. A., Daniels, L., Dooley, B., Muscatello, L., & O'Donnell, L. (2012) · EXPLORE · doi:10.1016/j.explore.2011.12.001 · Cited by 72
Sheppard, C., Higgins, B., Wise, M., Yiangou, C., Dubois, D., & Kilburn, S. A. (2009) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2008.11.005 · Cited by 72
“The FACT-B, plus the endocrine subscales, were scored using the authors scoring guidelines (Brady et al., 1997; Cella et al., 1993; Fallowfield et al., 1999).”
MethodQuality of Life determinants in women with breast cancer undergoing treatment with curative intent
Pandey, M., Thomas, B. C., SreeRekha, P., Ramdas, K., Ratheesan, K., Parameswaran, S., Mathew, B. S., & Rajan, B. (2005) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-3-63 · Cited by 72
“Patients and methods: Functional Assessment of Cancer Therapy-Breast (FACT-B) Version 4 Malayalam was used to assess quality of life in 502 breast cancer patients undergoing treatment with curative intent.”
MethodInfluentialCortés, J., Baselga, J. M., Im, Y., Im, S., Pivot, X. B., Ross, G. A., Clark, E., Knott, A., & Swain, S. M. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt274 · Cited by 71
“In women with breast cancer, HRQoL may be adversely affected by general cancer-related factors, such as fatigue, pain, and concerns about the illness, along with breast cancer-specific considerations, such as perceived attractiveness or sense of femininity [13].”
BackgroundMethodMemorial Symptom Assessment Scale
Chang, V. T.-S., Hwang, S. S., Thaler, H. T., Kasimis, B. S., & Portenoy, R. K. (2004) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.4.2.171 · Cited by 71
LeBlanc, T. W., Nipp, R. D., Rushing, C. N., Samsa, G., Locke, S. C., Kamal, A. H., Cella, D. F., & Abernethy, A. P. (2014) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2014.09.008 · Cited by 71
Self-citationNidich, S. I., Fields, J. Z., Rainforth, M. V., Pomerantz, R. W., Cella, D. F., Kristeller, J. L., Salerno, J. W., & Schneider, R. H. (2009) · Integrative Cancer Therapies · doi:10.1177/1534735409343000 · Cited by 73
“A treatment effect size of .25 was assumed based on data reported by Brady et al.51 Also based on Brady et al,51 the standard deviation of the FACT-B scores was assumed to be 13.7 and the test–retest correlation was set at .85.”
BackgroundMethodInfluentialSelf-citationExpressive writing in early breast cancer survivors
Craft, M. A., Davis, G. C., & Paulson, R. M. (2013) · Journal of Advanced Nursing · doi:10.1111/j.1365-2648.2012.06008.x · Cited by 70
Brusilovskiy, E., Mitstifer, M., & Salzer, M. S. (2009) · Journal of Psychosocial Oncology · doi:10.1080/07347330802614774 · Cited by 70
“The FACT-G has been well validated and shown to be quite reliable (e.g., Cella et al., 1993; Winstead-Fry & Schultz, 1997), and the breast cancer–specific module has also been shown to have acceptable reliability and to be sensitive to change in performance status rating (Brady et al., 1997).”
BackgroundMethodExercise and Quality of Life Outcomes in Patients With Cancer
Knobf, M. T., Musanti, R. M., & Dorward, J. (2007) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2007.08.007 · Cited by 70
Advances in quality of life measurements in oncology patients
Cella, D. F., Chang, C., LAI, J., & WEBSTER, K. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70176-0 · Cited by 69
Self-citationJohnson, E. A., Marks, R. S., Mandrekar, S. J., Hillman, S. L., Hauge, M. D., Bauman, M. D., Wos, E. J., Moore, D. F., Kugler, J. W., Windschitl, H. E., et al. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2007.10.003 · Cited by 70
Spector, D., Deal, A. M., Amos, K. D., Yang, H., & Battaglini, C. L. (2013) · Integrative Cancer Therapies · doi:10.1177/1534735413503546 · Cited by 70
“The FACT-B has been validated for assessment of quality of life in breast cancer patients of various racial/ethnic backgrounds.(35,36) This instrument has 42 items and consists of the FACT–General (FACT-G) and a breast cancer–specific subscale.”
MethodNapoli, A., Bazzocchi, A., Scipione, R., Anzidei, M., Saba, L., Ghanouni, P., Cozzi, D. A., & Catalano, C. (2017) · Radiology · doi:10.1148/radiol.2017162680 · Cited by 70
Moreno, P. I., Ramírez, A. G., Miguel‐Majors, S. L. S., Castillo, L., Fox, R. S., Gallion, K. J., Muñoz, E., Estabrook, R., Perez, A., Lad, T. E., et al. (2018) · Supportive Care in Cancer · doi:10.1007/s00520-018-4426-4 · Cited by 72
Psycho-Spiritual Integrative Therapy for Women with Primary Breast Cancer
Garlick, M., Wall, K., Corwin, D., & Koopman, C. (2011) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-011-9224-9 · Cited by 69
“Also, women showed improvement on the FACIT-Sp-Ex (Functional Assessment of Chronic Illness Therapy-Spiritual) Meaning/Peace subscale, the Spiritual Well-being total scale (p \ .01), and on the New Possibilities (p \ .01) and Personal Strength (p \ .05) subscales of the Posttraumatic Growth Inventory (PTGI).”
BackgroundMethodInfluentialEster, M., Culos-Reed, S. N., Abdul‐Razzak, A., Daun, J. T., Duchek, D., Francis, G. J., Bebb, G. D., Black, J., Arlain, A., Gillis, C., et al. (2021) · BMC Cancer · doi:10.1186/s12885-021-07872-y · Cited by 70
Michael, M., & Tannock, I. F. (1998) · Europe PMC (PubMed Central) · Cited by 69
Chee, W., Lee, Y., Im, E., Chee, E., Tsai, H., Nishigaki, M., Yeo, S. A., Schapira, M. M., & Mao, J. J. J. (2016) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x16658369 · Cited by 69
Gordon, L. G., Battistutta, D., Scuffham, P., Tweeddale, M., & Newman, B. M. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-5151-5 · Cited by 68
“The FACT-B performs very well for ease of administration, brevity, reliability, validity and sensitivity to change in a US population [12].”
BackgroundShaw, B. R., DuBenske, L. L., Han, J. Y., Cofta-Woerpel, L. M., Bush, N. E., Gustafson, D. H., & Mctavish, F. M. (2008) · Journal of Health Communication · doi:10.1080/10810730802063546 · Cited by 70
“…minutes) in each of the following types of topics during the 4-month study period: (1) psychosocial topics (information about psychological and social issues); C-SHIP Model Factors Cancer-relevant encodings and self-construals Functional well-being Brady et al., 1997; Cella et al., 2003 5 0–4 .84”
BackgroundAnders, C. K., Deal, A. M., Abramson, V. G., Liu, M., Storniolo, A. M., Carpenter, J. T., Puhalla, S., Nanda, R., Melhem‐Bertrandt, A., Lin, N., et al. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3039-y · Cited by 68
“org) [21–23].”
Milne, H. M., Gordon, S., Guilfoyle, A. M., Wallman, K. E., & Courneya, K. S. (2007) · Psycho-Oncology · doi:10.1002/pon.1211 · Cited by 68
The trajectory of religious coping across time in response to the diagnosis of breast cancer
Gall, T. L., Guirguis‐Younger, M., Charbonneau, C., & Florack, P. (2009) · Psycho-Oncology · doi:10.1002/pon.1495 · Cited by 67
Alderman, A. K., & Salem, B. (2010) · Plastic and Reconstructive Surgery · doi:10.1097/prs.0b013e3181ea44f9 · Cited by 68
Cunningham, A. J., Edmonds, C. V. I., Jenkins, G., Pollack, H. B., Lockwood, G. A., & Warr, D. G. (1998) · Psycho-Oncology · doi:10.1002/(sici)1099-1611(199811/12)7:6 · Cited by 276
Self-citationFagundes, C. P., Lindgren, M. E., Shapiro, C. L., & Kiecolt‐Glaser, J. K. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.06.022 · Cited by 67
Scott, J. M., Thomas, S. M., Peppercorn, J. M., Herndon, J. E., Douglas, P. S., Khouri, M. G., Dang, C. T., Yu, A. F., Catalina, D., Ciolino, C., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.043483 · Cited by 74
“ER−/PR−/HER2− 30 (17) 6 (12) 13 (22) 11 (19)”
Patient-Reported Outcomes in Breast Oncology: A Review of Validated Outcome Instruments
Kanatas, A. N., Velikova, G., Roe, B. H., Horgan, K. J., Ghazali, N., Shaw, R., & Rogers, S. N. (2012) · Tumori Journal · doi:10.1177/030089161209800602 · Cited by 67
Wagner, D., Thomssen, C., Haerting, J., & Unverzagt, S. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008941.pub2 · Cited by 65
Belkacémi, Y., Chauvet, M., Giard, S., Villette, S., Lacornerie, T., Bonodeau, F., Baranzelli, M., Bonneterre, J. M., & Lartigau, E. F. (2008) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2008.06.004 · Cited by 66
Thewes, B., Meiser, B., Duric, V. M., Stockler, M. R., Taylor, A., Stuart‐Harris, R. C., Links, M. J., Wilcken, N. R. C., McLachlan, S. A., Phillips, K., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70254-0 · Cited by 65
Neil‐Sztramko, S., Klika, R. J., Garland, S. J., McKenzie, D. C., & Campbell, K. L. (2012) · Supportive Care in Cancer · doi:10.1007/s00520-012-1600-y · Cited by 71
van Ommen‐Nijhof, A., Konings, I. R. H. M., van Zeijl, C. J. J., Groot, C. A. U., van der Noort, V., Jager, A., & Sonke, G. S. (2018) · BMC Cancer · doi:10.1186/s12885-018-4978-1 · Cited by 66
Quality of Life After Bilateral Prophylactic Mastectomy
Geiger, A. M., Nekhlyudov, L., Herrinton, L. J., Rolnick, S. J., Greene, S. M., West, C. N., Harris, E. L., Elmore, J. G., Altschuler, A., Liu, I.-L. A., et al. (2006) · Annals of Surgical Oncology · doi:10.1245/s10434-006-9206-6 · Cited by 66
Metadata
- Authors
- Brady, M. J., Cella, D. F., Mo, F., Bonomi, A. E., Tulsky, D. S., Lloyd, S. R., Deasy, S., Cobleigh, M., & Shiomoto, G.
- Affiliations
- Rush University Medical Center (US)
- Rush University (US)
- Venue
- Journal of Clinical Oncology
- Published
- 1997-03
- Volume
- 15
- Issue
- 3
- Pages
- 974-986
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1857624176
- Cited by
- 1,752
- References
- 39
- Citations by year
- 2026: 47 · 2025: 76 · 2024: 77 · 2023: 71 · 2022: 97 · 2021: 88 · 2020: 78 · 2019: 87 · 2018: 83 · 2017: 85 · 2016: 83 · 2015: 73 · 2014: 83 · 2013: 70 · 2012: 86
- FWCI
- 5.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Oncology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1r29ca051926-01a1)
- National Cancer Institute (R29CA51926)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Nursing › Research and Theory › Health Education and Validation
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- FACT-B, breast cancer, quality of life, FACT-G, instrument validation, sensitivity to change, test-retest reliability, internal consistency, known-groups validity, convergent validity, discriminant validity, physical well-being, functional well-being, emotional well-being, Functional Living Index-Cancer, self-report questionnaire
- MeSH terms
- Adult, Aged, Aged, 80 and over, Breast Neoplasms, Female, Humans, Middle Aged, Quality of Life, Self Concept, Sensitivity and Specificity, Severity of Illness Index, Translations, Reproducibility of Results
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review